Joel Beatty
Stock Analyst at Baird
(1.89)
# 1083
Out of 5,329 analysts
263
Total ratings
38.93%
Success rate
16.99%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALKS Alkermes | Maintains: Outperform | 38 41 | 30.63 | 33.86% | 3 | May 2, 2025 | |
LRMR Larimar Therapeutics | Maintains: Outperform | 13 10 | 2.85 | 250.88% | 2 | Mar 25, 2025 | |
MNMD Mind Medicine | Maintains: Outperform | 27 16 | 6.62 | 141.69% | 2 | Mar 7, 2025 | |
CTNM Contineum Therapeuti... | Maintains: Outperform | 32 16 | 3.98 | 302.01% | 2 | Mar 7, 2025 | |
ARGX argenx | Maintains: Neutral | 650 680 | 638.88 | 6.44% | 6 | Mar 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 117 73 | 38.16 | 91.3% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 32 | 24.32 | 31.58% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 132 160 | 112.47 | 42.26% | 4 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 8 | 5.64 | 41.84% | 4 | Feb 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 31 | 16.11 | 92.43% | 1 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 8 | 1.62 | 393.83% | 3 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 70 | 49.5 | 41.41% | 14 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 30.21 | 148.26% | 1 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 154 162 | 117.19 | 38.24% | 3 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 3 11 | 5.14 | 114.01% | 4 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 1.69 | 314.2% | 5 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 72 | 15.43 | 366.62% | 2 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 65 | 62.7 | 3.67% | 5 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 240 175 | 62.23 | 181.21% | 4 | Oct 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 9 | 7.5 | 20% | 4 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 127 | 99.27 | 27.93% | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 58 | 21.88 | 165.08% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 60 | n/a | n/a | 2 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 72 | 38.96 | 84.8% | 4 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 20 | 0.48 | 4066.67% | 3 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 28 | 14.59 | 91.91% | 3 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 | 1.42 | 216.9% | 2 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 103 | n/a | n/a | 2 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 11.2 | 123.21% | 3 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 9 | 0.41 | 2095.12% | 2 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | n/a | n/a | 3 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 28 | 13.78 | 103.19% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Sep 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 60 | n/a | n/a | 3 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 7.6 | 110.53% | 1 | Jun 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 2 | 1.81 | -30.94% | 2 | May 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | 1.61 | 2632.92% | 3 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 58 | 14.06 | 312.52% | 6 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 24 | 20.47 | 17.24% | 2 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 | 12.54 | 43.54% | 3 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 6 | 2.71 | 121.4% | 2 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 31 | 1.33 | 2230.83% | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 36 28 | 6.11 | 358.27% | 2 | Mar 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 170 175 | 255.12 | -31.4% | 2 | Feb 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 | 4.45 | 214.61% | 8 | Jan 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 108 | 62.8 | 71.97% | 7 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 74 | n/a | n/a | 2 | Oct 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 78 | 31.79 | 145.36% | 3 | Aug 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 440 160 | n/a | n/a | 2 | Jun 11, 2020 |